Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22,672,988
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
17,706,224
-
Shares change
-
-186,413
-
Total reported value, excl. options
-
$1,079,385,907
-
Value change
-
-$8,059,152
-
Put/Call ratio
-
14%
-
Number of buys
-
92
-
Number of sells
-
-76
-
Price
-
$61.02
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q2 2021
206 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q2 2021.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,706,224 shares
of 22,672,988 outstanding shares and own 78.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,942,163 shares), Conestoga Capital Advisors, LLC (1,825,803 shares), VANGUARD GROUP INC (1,147,171 shares), Copeland Capital Management, LLC (1,063,033 shares), GENEVA CAPITAL MANAGEMENT LLC (903,722 shares), STATE STREET CORP (696,321 shares), DIMENSIONAL FUND ADVISORS LP (691,722 shares), Ranger Investment Management, L.P. (493,754 shares), KENNEDY CAPITAL MANAGEMENT, INC. (372,127 shares), and AMERIPRISE FINANCIAL INC (336,824 shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.